PAMCX
Price
$103.39
Change
-$0.73 (-0.70%)
Updated
Sep 20 closing price
SMXAX
Price
$18.89
Change
-$0.14 (-0.74%)
Updated
Sep 20 closing price
Ad is loading...

PAMCX vs SMXAX

Header iconPAMCX vs SMXAX Comparison
Open Charts PAMCX vs SMXAXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$103.39
Change-$0.73 (-0.70%)
VolumeN/A
CapitalizationN/A
SEI Extended Market Index A (SIIT)
Price$18.89
Change-$0.14 (-0.74%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PAMCX vs SMXAX Comparison Chart
Loading...
VS
PAMCX vs. SMXAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongBuy and SMXAX is a Buy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.4B vs. SMXAX (1.16B). SMXAX pays higher dividends than PAMCX: SMXAX (1.10) vs PAMCX (0.00). PAMCX was incepted earlier than SMXAX: PAMCX (24 years) vs SMXAX (12 years). SMXAX is a more actively managed with annual turnover of: 34.00 vs. PAMCX (21.70). PAMCX has a lower initial minimum investment than SMXAX: PAMCX (2500) vs SMXAX (100000). SMXAX annual gain was more profitable for investors over the last year : 28.09 vs. PAMCX (14.18). SMXAX return over 5 years is better than : 28.07 vs. PAMCX (12.05).
PAMCXSMXAXPAMCX / SMXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years12 years-
Gain YTD8.82011.90074%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.16B2,709%
Annual Yield % from dividends0.001.10-
Returns for 1 year14.1828.0950%
Returns for 3 years-14.88-15.8794%
Returns for 5 years12.0528.0743%
Returns for 10 years38.6366.5558%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCTO2.610.42
+19.17%
Eightco Holdings Inc
UFI7.700.11
+1.45%
UNIFI
ALKT31.64-0.41
-1.28%
Alkami Technology
BXP81.02-1.29
-1.57%
BXP Inc.
TRDA14.69-0.31
-2.07%
Entrada Therapeutics